Adial ceo to present at the spring microcap rodeo conference on june 6th

Glen allen, va., may 29, 2024 (globe newswire) -- adial pharmaceuticals, inc. (nasdaq: adil) (“adial” or the “company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it will be participating in the spring microcap rodeo conference that will be held on thursday, june 6, 2024 in new york city.
ADIL Ratings Summary
ADIL Quant Ranking